Perspective Therapeutics, Inc.Perspective Therapeutics, Inc.Perspective Therapeutics, Inc.

Perspective Therapeutics, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪940.17 M‬USD
−0.09USD
‪−46.51 M‬USD
‪1.43 M‬USD
‪456.66 M‬
Beta (1Y)
0.05

About Perspective Therapeutics, Inc.

CEO
Johan M. Spoor
Headquarters
Seattle
Employees (FY)
119
Founded
1998
FIGI
BBG000BG5HT7
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1998 and is headquartered in Seattle, WA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CATX is 1.50 USD — it has decreased by 0.66% in the past 24 hours. Watch Perspective Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Perspective Therapeutics, Inc. stocks are traded under the ticker CATX.
CATX stock has fallen by 1.96% compared to the previous week, the month change is a 10.18% fall, over the last year Perspective Therapeutics, Inc. has showed a 200.00% increase.
We've gathered analysts' opinions on Perspective Therapeutics, Inc. future price: according to them, CATX price has a max estimate of 3.00 USD and a min estimate of 1.70 USD. Watch CATX chart and read a more detailed Perspective Therapeutics, Inc. stock forecast: see what analysts think of Perspective Therapeutics, Inc. and suggest that you do with its stocks.
CATX reached its all-time high on Feb 11, 1988 with the price of 243.75 USD, and its all-time low was 0.003 USD and was reached on Apr 8, 2004. View more price dynamics on CATX chart.
See other stocks reaching their highest and lowest prices.
CATX stock is 15.97% volatile and has beta coefficient of 0.05. Track Perspective Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Perspective Therapeutics, Inc. there?
Today Perspective Therapeutics, Inc. has the market capitalization of ‪940.17 M‬, it has increased by 10.37% over the last week.
Yes, you can track Perspective Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Perspective Therapeutics, Inc. is going to release the next earnings report on Aug 9, 2024. Keep track of upcoming events with our Earnings Calendar.
CATX earnings for the last quarter are −0.02 USD per share, whereas the estimation was −0.03 USD resulting in a 28.57% surprise. The estimated earnings for the next quarter are −0.02 USD per share. See more details about Perspective Therapeutics, Inc. earnings.
Perspective Therapeutics, Inc. revenue for the last quarter amounts to ‪325.00 K‬ USD despite the estimated figure of ‪368.80 K‬ USD. In the next quarter revenue is expected to reach ‪83.00 K‬ USD.
CATX net income for the last quarter is ‪−12.28 M‬ USD, while the quarter before that showed ‪−10.36 M‬ USD of net income which accounts for −18.62% change. Track more Perspective Therapeutics, Inc. financial stats to get the full picture.
No, CATX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 24, 2024, the company has 119.00 employees. See our rating of the largest employees — is Perspective Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Perspective Therapeutics, Inc. EBITDA is ‪−29.83 M‬ USD, and current EBITDA margin is ‪−2.78 K‬%. See more stats in Perspective Therapeutics, Inc. financial statements.
Like other stocks, CATX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Perspective Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Perspective Therapeutics, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Perspective Therapeutics, Inc. stock shows the buy signal. See more of Perspective Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.